Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis

Osteoporosis International

Volumn 12, Issue 12, 2001, Pages 1031-1035

  Lange, U ^a   Jung, O ^b   Teichmann, J ^a   Neeck, G ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Ankylosing spondylitis; Disease activity; Osteopenia; Osteoporosis; Vitamin D metabolism

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; C REACTIVE PROTEIN; CALCITRIOL; IMMUNOMODULATING AGENT; PARATHYROID HORMONE; PYRIDINIUM DERIVATIVE; VITAMIN D;

ADOLESCENT; ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; BONE ATROPHY; BONE TURNOVER; CALCIUM BALANCE; CONTROLLED STUDY; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; METABOLITE; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VERTEBRA FRACTURE; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM;

ADOLESCENT; ADULT; AGED; ALKALINE PHOSPHATASE; BONE REMODELING; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PARATHYROID HORMONE; PYRIDINIUM COMPOUNDS; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; STEROID HYDROXYLASES; VITAMIN D;

EID: 0035700604     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001980170013     Document Type: Article

References (32)

1. Osteoporosis in early ankylosing spondylitis: A primary pathological event?
2. Bone densitometry measurements in early inflammatory disease
3. Significant loss of bone mass in patients with early, active ankylosing spondylitis
4. Role of cytokines in bone resorption
5. Bone marrow, clastic and blastic cell system: Quo vadis?
6. Cytokines and osteoclast activity
7. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy
8. Interleukin-1 β stimulates bone resorption and inhibits bone formation in vivo
9. 3 on cell proliferation and calcitonin gene expression
10. Structure-function relationships in the vitamin D endocrine system
11. 3 selectively reduces interleukin-2 levels and proliferation of human T-cell lines in vitro
12. New York clinical criteria for ankylosing spondylitis: A statistical evaluation
13. A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index
14. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis
15. Interpretation of serum total calcium: Effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual
16. Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis
17. Fracture risk in patients with ankylosing spondylitis: A population based study
18. Appendicular and vertebral bone mass in ankylosing spondylitis: A comparison of plain radiographs with single- and dual-photon absorptiometry and with quantitative computed tomography
19. Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis
20. Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis
21. A lower femoral neck BMD occurs in patients with ankylosing spondylitis (AS) compared with their normal sex siblings
22. Calcium and vitamin D metabolism in granulomatous diseases
23. Serum osteocalcin and vitamin D metabolites in patients with ankylosing spondylitis
24. Cyclooxygenase enhances cell growth in an osteoblastic cell line, MC3T3-E1
25. Calciotropic hormones and ageing
26. Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis
27. Bone turnover in non-steroid-treated rheumatoid arthritis
28. 3
29. Influence of inflammation and corticosteroid treatment on indices of bone turnover and parathyroid function
30. Vitamin D metabolism in rats with adjuvant-induced arthritis
31. Comparison of the effects of intermittent and continuous administration of human parathyroid hormone (1-34) on rat bone
32. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis